These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 22008843

  • 1. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.
    Valenzuela R, Videla LA.
    Food Funct; 2011 Nov; 2(11):644-8. PubMed ID: 22008843
    [Abstract] [Full Text] [Related]

  • 2. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
    Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O, Maluenda F, Diaz JC, Rencoret G, Braghetto I, Castillo J, Poniachik J, Videla LA.
    Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
    [Abstract] [Full Text] [Related]

  • 3. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
    Elizondo A, Araya J, Rodrigo R, Signorini C, Sgherri C, Comporti M, Poniachik J, Videla LA.
    Biol Res; 2008 Nov; 41(1):59-68. PubMed ID: 18769764
    [Abstract] [Full Text] [Related]

  • 4. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J.
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [Abstract] [Full Text] [Related]

  • 5. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c.
    Dossi CG, Tapia GS, Espinosa A, Videla LA, D'Espessailles A.
    J Nutr Biochem; 2014 Sep; 25(9):977-84. PubMed ID: 24993917
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
    Videla LA, Rodrigo R, Araya J, Poniachik J.
    Free Radic Biol Med; 2004 Nov 01; 37(9):1499-507. PubMed ID: 15454290
    [Abstract] [Full Text] [Related]

  • 7. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb 01; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 8. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 01; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease.
    Valenzuela R, Ortiz M, Hernández-Rodas MC, Echeverría F, Videla LA.
    Curr Med Chem; 2020 Sep 01; 27(31):5250-5272. PubMed ID: 30968772
    [Abstract] [Full Text] [Related]

  • 13. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
    Elizondo A, Araya J, Rodrigo R, Poniachik J, Csendes A, Maluenda F, Díaz JC, Signorini C, Sgherri C, Comporti M, Videla LA.
    Obesity (Silver Spring); 2007 Jan 01; 15(1):24-31. PubMed ID: 17228028
    [Abstract] [Full Text] [Related]

  • 14. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, Heathcote JE.
    J Hepatol; 2008 Feb 01; 48(2):300-7. PubMed ID: 18086506
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M.
    Int J Mol Med; 2008 Nov 01; 22(5):663-7. PubMed ID: 18949388
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.
    Pettinelli P, Videla LA.
    J Clin Endocrinol Metab; 2011 May 01; 96(5):1424-30. PubMed ID: 21325464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration.
    Barrera C, Valenzuela R, Rincón MÁ, Espinosa A, Echeverria F, Romero N, Gonzalez-Mañan D, Videla LA.
    Free Radic Biol Med; 2018 Oct 01; 126():313-321. PubMed ID: 30153476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.